World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 83 15651 14722 7878 7285 658 24227

Alberto J. Espay publications per year

The chart shows the history of publications by Alberto J. Espay between 2001 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Alberto J. Espay published across 26 years, from 2001 to 2026, averaging 27.8 papers a year. Output peaked at 131 publications in 2020. 60 of the 724 publications appeared in the last two years.

No. of publications
25 50 75 100 125
Bar chart. Horizontal axis: year, 2001 to 2026. Vertical axis: number of publications, 0 to 131. Peak 131 publications in 2020. 2001: 2 publications 2002: 2 publications 2003: 2 publications 2004: 0 publications 2005: 5 publications 2006: 9 publications 2007: 5 publications 2008: 6 publications 2009: 9 publications 2010: 10 publications 2011: 14 publications 2012: 19 publications 2013: 21 publications 2014: 20 publications 2015: 22 publications 2016: 47 publications 2017: 44 publications 2018: 47 publications 2019: 53 publications 2020: 131 publications 2021: 55 publications 2022: 42 publications 2023: 53 publications 2024: 46 publications 2025: 56 publications 2026: 4 publications
2001 2026

724 publications in total across all disciplines

View publications per year as a table
Alberto J. Espay: publications per year, 2001 to 2026
Year Publications
2001 2
2002 2
2003 2
2004 0
2005 5
2006 9
2007 5
2008 6
2009 9
2010 10
2011 14
2012 19
2013 21
2014 20
2015 22
2016 47
2017 44
2018 47
2019 53
2020 131
2021 55
2022 42
2023 53
2024 46
2025 56
2026 4
Total 724
Download as CSV

Alberto J. Espay publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alberto J. Espay sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 641–660 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 658 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371 658
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Alberto J. Espay D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alberto J. Espay sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 82–83 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027 83
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Alberto J. Espay is affiliated with the University of Cincinnati in the United States. Their research primarily focuses on medical and neuroscientific aspects, with notable contributions in the fields of medicine and neuroscience. They have published extensively in subfields such as neurology, psychiatry and mental health, cellular and molecular neuroscience, physiology, and cognitive neuroscience.

The scholar's main research topics include Parkinson's disease mechanisms and treatments, neurological disorders and treatments, genetic neurodegenerative diseases, Alzheimer's disease research and treatments, botulinum toxin and related neurological disorders, dementia and cognitive impairment research, and autism spectrum disorder research.

Their frequent publication venues indicate a strong presence in the following journals:

  • Movement Disorders Clinical Practice
  • Neurology
  • JAMA Neurology
  • Parkinsonism & Related Disorders
  • Movement Disorders

Recent notable papers authored or co-authored by Alberto J. Espay include:

  • "Long-term unsupervised mobility assessment in movement disorders," 2020, The Lancet Neurology
  • "Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals," 2023, Movement Disorders
  • "Initiation of pharmacological therapy in Parkinson's disease: when, why, and how," 2020, The Lancet Neurology
  • "Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda," 2021, NeuroImage Clinical
  • "Assessment of Emergency Department and Inpatient Use and Costs in Adult and Pediatric Functional Neurological Disorders," 2020, JAMA Neurology

Espay frequently collaborates with several researchers, including:

  • Daniel Weintraub
  • Federico Rodríguez-Porcel
  • Keith A. Josephs
  • Rhonna Shatz
  • Luca Marsili

Their contributions to academic literature also extend to book publications through Cambridge University Press. Two book titles listed are "Brain Fables" (2020) and "Common Pitfalls in Cognitive and Behavioral Neurology" (2020).

Best Publications

  • Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

    C Warren Olanow;Karl Kieburtz;Per Odin;Alberto J Espay

  • Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.

    Alberto J. Espay;Selma Aybek;Alan Carson;Mark J. Edwards

  • Technology in Parkinson's disease: Challenges and opportunities.

    Alberto J. Espay;Paolo Bonato;Fatta B. Nahab;Walter Maetzler

  • The Parkinson's progression markers initiative (PPMI): establishing a PD biomarker cohort

    Kenneth Marek;Sohini Chowdhury;Andrew Siderowf;Shirley Lasch

  • Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke

    Linda S. Williams;J. Rotich;R. Qi;N. Fineberg

  • Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

    Ju-Hee Kang;Ju-Hee Kang;David J. Irwin;Alice S. Chen-Plotkin;Andrew Siderowf

  • Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.

    Francesca Morgante;Alberto J. Espay;Carolyn Gunraj;Anthony E. Lang

  • Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

    Daniel Weintraub;Tanya Simuni;Chelsea Caspell-Garcia;Christopher Coffey

  • A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy

    Mikko Muona;Samuel F. Berkovic;Leanne M. Dibbens;Karen L. Oliver

  • Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations

    Anthony E. Lang;Alberto J. Espay

  • Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.

    Alberto J. Espay;Francesca Morgante;Aristide Merola;Alfonso Fasano;Alfonso Fasano

  • Long-term unsupervised mobility assessment in movement disorders.

    Elke Warmerdam;Jeffrey M Hausdorff;Jeffrey M Hausdorff;Jeffrey M Hausdorff;Arash Atrsaei;Yuhan Zhou

  • A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

    Alberto J. Espay;Jeffrey M. Hausdorff;Jeffrey M. Hausdorff;Jeffrey M. Hausdorff;Álvaro Sánchez‐Ferro;Jochen Klucken

  • Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement

    Alberto J. Espay;Peter A. LeWitt;Horacio Kaufmann

  • Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.

    Hubert H. Fernandez;David G. Standaert;Robert A. Hauser;Anthony E. Lang

  • APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

    Ignacio F. Mata;James B. Leverenz;Daniel Weintraub;John Q. Trojanowski

  • Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

    Robert A. Hauser;Ann Hsu;Sherron Kell;Alberto J. Espay

  • The Modified Bradykinesia Rating Scale for Parkinson’s Disease: Reliability and Comparison with Kinematic Measures

    Dustin A. Heldman;Joseph P. Giuffrida;Robert Chen;Megan Payne

  • “On” state freezing of gait in Parkinson disease: A paradoxical levodopa-induced complication

    A.J. Espay;A. Fasano;B.F.L. van Nuenen;M.M. Payne

  • Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease: A Randomized Clinical Trial

    Michael A. Schwarzschild;Alberto Ascherio;M. Flint Beal;Merit E. Cudkowicz

Frequent Co-Authors

Anthony E. Lang
Anthony E. Lang University of Toronto
Daniel Weintraub
Daniel Weintraub University of Pennsylvania
Keith A. Josephs
Keith A. Josephs Mayo Clinic
Alfonso Fasano
Alfonso Fasano University Health Network
Francesca Morgante
Francesca Morgante St George's, University of London
Aristide Merola
Aristide Merola University of Cincinnati
Hubert H. Fernandez
Hubert H. Fernandez Cleveland Clinic
Leonardo Lopiano
Leonardo Lopiano University of Turin
Ziv Gan-Or
Ziv Gan-Or McGill University
Robert Chen
Robert Chen University Health Network

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean attending medical school. Many students are now turning to online degrees that align with the growing demand for healthcare professionals. Key options include Healthcare Administration, Nursing, Pharmacy, and Health Information Management—fields that are pivotal to efficient and effective healthcare delivery.

If you’re interested in the leadership and management side of healthcare, you might consider an affordable mha online program. For nurses aiming to advance their credentials, the most affordable dnp programs offer a flexible path to doctoral-level practice.

Aspiring pharmacists can benefit from online pharmacy programs that blend convenience and rigorous training. Meanwhile, students interested in the data and technology side of healthcare should explore an online mhi degree, equipping them to manage patient data and healthcare information systems.

These online degrees provide affordable and flexible pathways into rewarding healthcare careers, making it easier than ever to contribute to the rapidly evolving medical landscape in the USA.

Best Scientists Citing Alberto J. Espay

Trending Scientists

Recently Published Articles